Myotonic Dystrophy Drug Market Report

Global and Europe Myotonic Dystrophy Drug Market Professional Survey Report 2019

  • POSTDATE：Jun 04, 2020
  • PAGES：165
  • REPORT CODE：GMM535779
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Myotonic Dystrophy Drug market was valued at XX.0 million US$ in 2018, with the CAGR of 4.2%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Myotonic Dystrophy Drug market. Describe product range of Myotonic Dystrophy Drug, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Myotonic Dystrophy Drug market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Myotonic Dystrophy Drug market.

     

    By Player

    • Genzyme Corporation

    By Type

    • ISIS-DMPKRx

    • PRO-135

    • SRT-152

    • VAL-0411

    • Others

    By End-User

    • Hospital

    • Clinic

    • Home Use

    • Others

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Myotonic Dystrophy Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Myotonic Dystrophy Drug Market Size and Growth Rate of ISIS-DMPKRx from 2014 to 2026

      • 1.3.2 Global Myotonic Dystrophy Drug Market Size and Growth Rate of PRO-135 from 2014 to 2026

      • 1.3.3 Global Myotonic Dystrophy Drug Market Size and Growth Rate of SRT-152 from 2014 to 2026

      • 1.3.4 Global Myotonic Dystrophy Drug Market Size and Growth Rate of VAL-0411 from 2014 to 2026

      • 1.3.5 Global Myotonic Dystrophy Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Myotonic Dystrophy Drug Market Size and Growth Rate of Hospital from 2014 to 2026

      • 1.4.2 Global Myotonic Dystrophy Drug Market Size and Growth Rate of Clinic from 2014 to 2026

      • 1.4.3 Global Myotonic Dystrophy Drug Market Size and Growth Rate of Home Use from 2014 to 2026

      • 1.4.4 Global Myotonic Dystrophy Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Myotonic Dystrophy Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Myotonic Dystrophy Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Myotonic Dystrophy Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Myotonic Dystrophy Drug Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Myotonic Dystrophy Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Myotonic Dystrophy Drug by Major Types

      • 3.4.1 Myotonic Dystrophy Drug Market Size and Growth Rate of ISIS-DMPKRx

      • 3.4.2 Myotonic Dystrophy Drug Market Size and Growth Rate of PRO-135

      • 3.4.3 Myotonic Dystrophy Drug Market Size and Growth Rate of SRT-152

      • 3.4.4 Myotonic Dystrophy Drug Market Size and Growth Rate of VAL-0411

      • 3.4.5 Myotonic Dystrophy Drug Market Size and Growth Rate of Others

    4 Segmentation of Myotonic Dystrophy Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Myotonic Dystrophy Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Myotonic Dystrophy Drug for Hospital

      • 4.4.2 Market Size and Growth Rate of Myotonic Dystrophy Drug for Clinic

      • 4.4.3 Market Size and Growth Rate of Myotonic Dystrophy Drug for Home Use

      • 4.4.4 Market Size and Growth Rate of Myotonic Dystrophy Drug for Others

    5 Market Analysis by Major Regions

    • 5.1 Global Myotonic Dystrophy Drug Production Analysis by Top Regions

    • 5.2 Global Myotonic Dystrophy Drug Consumption Analysis by Top Regions

    • 5.3 Global Myotonic Dystrophy Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Myotonic Dystrophy Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Myotonic Dystrophy Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Myotonic Dystrophy Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Myotonic Dystrophy Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Myotonic Dystrophy Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Myotonic Dystrophy Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Myotonic Dystrophy Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Myotonic Dystrophy Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Myotonic Dystrophy Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Myotonic Dystrophy Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Myotonic Dystrophy Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Myotonic Dystrophy Drug Landscape Analysis

    • 7.1 North America Myotonic Dystrophy Drug Landscape Analysis by Top Countries

      • 7.1.1 United States Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 7.1.2 Canada Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 7.1.3 Mexico Myotonic Dystrophy Drug Market Volume and Growth Rate

    8. Europe Myotonic Dystrophy Drug Landscape Analysis

    • 8.1 Europe Myotonic Dystrophy Drug Landscape Analysis by Major Types

    • 8.2 Europe Myotonic Dystrophy Drug Landscape Analysis by Major End-Users

    • 8.3 Europe Myotonic Dystrophy Drug Landscape Analysis by Top Countries

      • 8.3.1 Germany Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.2 UK Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.3 France Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.4 Italy Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.5 Spain Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.6 Belgium Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.7 Poland Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.8 Russia Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.9 Turkey Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.10 Netherlands Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.11 Portugal Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.12 Denmark Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.13 Finland Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.14 Iceland Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.15 Norway Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 8.3.16 Sweden Myotonic Dystrophy Drug Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Myotonic Dystrophy Drug Landscape Analysis

    • 9.1 Asia Pacific Myotonic Dystrophy Drug Landscape Analysis by Top Countries

      • 9.1.1 China Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 9.1.2 Japan Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 9.1.4 India Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 9.1.5 ASEAN Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 9.1.6 South Korea Myotonic Dystrophy Drug Market Volume and Growth Rate

    10 LAMEA Myotonic Dystrophy Drug Landscape Analysis

    • 10.1 LAMEA Myotonic Dystrophy Drug Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 10.1.2 Brazil Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 10.1.3 North Africa Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 10.1.4 South Africa Myotonic Dystrophy Drug Market Volume and Growth Rate

      • 10.1.5 Argentina Myotonic Dystrophy Drug Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Genzyme Corporation

      • 11.1.1 Genzyme Corporation Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 98 Figures and 137 Tables)

    • Figure Product Picture

    • Figure Myotonic Dystrophy Drug Market Size and Growth Rate of ISIS-DMPKRx from 2014 to 2026

    • Figure Myotonic Dystrophy Drug Market Size and Growth Rate of PRO-135 from 2014 to 2026

    • Figure Myotonic Dystrophy Drug Market Size and Growth Rate of SRT-152 from 2014 to 2026

    • Figure Myotonic Dystrophy Drug Market Size and Growth Rate of VAL-0411 from 2014 to 2026

    • Figure Myotonic Dystrophy Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of Home Use from 2014 to 2026

    • Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure North America Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure United States Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure China Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure India Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Myotonic Dystrophy Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Myotonic Dystrophy Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Myotonic Dystrophy Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Myotonic Dystrophy Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Myotonic Dystrophy Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of ISIS-DMPKRx

    • Figure Market Size and Growth Rate of PRO-135

    • Figure Market Size and Growth Rate of SRT-152

    • Figure Market Size and Growth Rate of VAL-0411

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Myotonic Dystrophy Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Myotonic Dystrophy Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Home Use

    • Figure Market Size and Growth Rate of Others

    • Table Global Myotonic Dystrophy Drug Production by Major Regions

    • Table Global Myotonic Dystrophy Drug Production Share by Major Regions

    • Table Global Myotonic Dystrophy Drug Consumption by Major Regions

    • Table Global Myotonic Dystrophy Drug Consumption Share by Major Regions

    • Table North America Myotonic Dystrophy Drug Production, Import, Consumption and Export Analysis

    • Table Europe Myotonic Dystrophy Drug Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Myotonic Dystrophy Drug Production, Import, Consumption and Export Analysis

    • Table LAMEA Myotonic Dystrophy Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Myotonic Dystrophy Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Myotonic Dystrophy Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Myotonic Dystrophy Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Myotonic Dystrophy Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Myotonic Dystrophy Drug Consumption by Major Countries from 2014 to 2026

    • Table North America Myotonic Dystrophy Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Myotonic Dystrophy Drug Consumption Share by Major Countries in 2014

    • Figure North America Myotonic Dystrophy Drug Consumption Share by Major Countries in 2018

    • Figure North America Myotonic Dystrophy Drug Consumption Share by Major Countries in 2026

    • Figure United States Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Myotonic Dystrophy Drug Consumption by Types from 2014 to 2026

    • Table Europe Myotonic Dystrophy Drug Consumption Share by Types from 2014 to 2026

    • Table Europe Myotonic Dystrophy Drug Consumption by End-Users from 2014 to 2026

    • Table Europe Myotonic Dystrophy Drug Consumption Share by End-Users from 2014 to 2026

    • Table Europe Myotonic Dystrophy Drug Consumption by Major Countries from 2014 to 2026

    • Table Europe Myotonic Dystrophy Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure France Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Myotonic Dystrophy Drug Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Myotonic Dystrophy Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure China Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure India Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Myotonic Dystrophy Drug Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Myotonic Dystrophy Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Myotonic Dystrophy Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Genzyme Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genzyme Corporation

    • Figure Sales and Growth Rate Analysis of Genzyme Corporation

    • Figure Revenue and Market Share Analysis of Genzyme Corporation

    • Table Product and Service Introduction of Genzyme Corporation

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US